Akadeum's microbubble-based cell isolation workflow addresses critical bottlenecks in cell therapy manufacturing by providing a scalable, gentle, and fully closed GMP solution for cell separation.

With products that gently isolate and activate cells, Akadeum's founder and CEO will discuss the impact the company is having on the cell and gene therapy space. ANN ARBOR, Mich., Jan. 7, 2024 ...

A team of researchers from Caltech and the University of Southern California has developed a microrobot for drug delivery ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to ...

DALLAS, Jan. 21, 2025 /PRNewswire/ -- Akadeum Life Sciences(R)' successful early access program for the Alerion(TM) Microbubble Cell Separation System confirmed the Alerion(TM) to be the highest ...

Akadeum has been successfully customer-audited per US and EU GMP standards, and the products meet endotoxin, sterility, and viral requirements per USP and ICH standards. As expected for raw materials ...

The MarketWatch News Department was not involved in the creation of this content. ANN ARBOR, Mich., Jan. 8, 2026 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant microbubble cell ...

Technology based on Bracco’s clinically validated microbubble technology enables gentle, scalable cell selection and activation, streamlining workflows for cell therapy Bracco’s microbubbles, an ...

Bracco Imaging SpA and Sonothera Inc. have entered into an agreement under which Bracco Imaging will provide its cutting-edge gas-filled microbubbles technology platform to Sonothera for use in the ...